BioCentury
ARTICLE | Company News

NeoGenomics sales and marketing update

December 8, 2014 8:00 AM UTC

NeoGenomics launched new tests to detect mutations in the Bruton’s tyrosine kinase (BtK) and phospholipase C gamma 2 (phosphatidylinositol-specific; PLCG2) genes for predicting acquired resistance t...